My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 155

    1.

    The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on insulin sensitivity and insulin metabolism interact with size at birth.

    Eriksson JG, Lindi V, Uusitupa M, Forsén TJ, Laakso M, Osmond C, Barker DJ.

    Diabetes. 2002 Jul;51(7):2321-4.PMID: 12086968 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    [Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus]

    Fu M, Chen H, Li X, Li J, Wu B, Cheng L, Cai M, Fu Z.

    Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002 Jun;19(3):234-8. Chinese. PMID: 12048686 [PubMed - indexed for MEDLINE]Related articles

    3.

    Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant caucasians.

    Ek J, Andersen G, Urhammer SA, Hansen L, Carstensen B, Borch-Johnsen K, Drivsholm T, Berglund L, Hansen T, Lithell H, Pedersen O.

    Diabetologia. 2001 Sep;44(9):1170-6.PMID: 11596673 [PubMed - indexed for MEDLINE]Related articles

    4.

    The effects of the Pro12Ala polymorphism of the PPARgamma-2 gene on lipid metabolism interact with body size at birth.

    Eriksson J, Lindi V, Uusitupa M, Forsén T, Laakso M, Osmond C, Barker D.

    Clin Genet. 2003 Oct;64(4):366-70.PMID: 12974743 [PubMed - indexed for MEDLINE]Related articles

    5.

    Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study.

    Herrmann SM, Ringel J, Wang JG, Staessen JA, Brand E; Berlin Diabetes Mellitus (BeDiaM) Study.

    Diabetes. 2002 Aug;51(8):2653-7.PMID: 12145184 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Association of the PRO12ALA polymorphism of the PPAR-gamma2 gene with oxidized low-density lipoprotein and cardiolipin autoantibodies in nondiabetic and type 2 diabetic subjects.

    Niskanen L, Lindi V, Erkkilä A, Sivenius K, Luoma J, Ylä-Herttuala S, Laakso M, Uusitupa MI.

    Metabolism. 2003 Feb;52(2):213-7.PMID: 12601635 [PubMed - indexed for MEDLINE]Related articles

    7.

    Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial.

    Andrulionytè L, Zacharova J, Chiasson JL, Laakso M; STOP-NIDDM Study Group.

    Diabetologia. 2004 Dec;47(12):2176-84. Epub 2004 Dec 8.PMID: 15592662 [PubMed - indexed for MEDLINE]Related articles

    8.

    Lack of association between the Pro12Ala polymorphism in PPAR-gamma2 gene and body weight changes, insulin resistance and chronic diabetic complications in obese patients with type 2 diabetes.

    Stefanski A, Majkowska L, Ciechanowicz A, Frankow M, Safranow K, Parczewski M, Pilarska K.

    Arch Med Res. 2006 Aug;37(6):736-43.PMID: 16824933 [PubMed - indexed for MEDLINE]Related articles

    9.

    The Pro12Ala polymorphism of the PPAR gamma 2 gene regulates weight from birth to adulthood.

    Pihlajamäki J, Vanhala M, Vanhala P, Laakso M.

    Obes Res. 2004 Feb;12(2):187-90.PMID: 14981210 [PubMed - indexed for MEDLINE]Related articles

    10.

    The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on glucose/insulin metabolism interact with prenatal exposure to famine.

    de Rooij SR, Painter RC, Phillips DI, Osmond C, Tanck MW, Defesche JC, Bossuyt PM, Michels RP, Bleker OP, Roseboom TJ.

    Diabetes Care. 2006 May;29(5):1052-7.PMID: 16644636 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Impact of Prol2Ala variant in the peroxisome proliferator-activated receptor (PPAR) gamma2 on obesity and insulin resistance in Japanese Type 2 diabetic and healthy subjects.

    Kawasaki I, Tahara H, Emoto M, Shoji T, Shioji A, Okuno Y, Inaba M, Nishizawa Y.

    Osaka City Med J. 2002 Jun;48(1):23-8.PMID: 12375694 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effect of experimental elevation of free fatty acids on insulin secretion and insulin sensitivity in healthy carriers of the Pro12Ala polymorphism of the peroxisome proliferator--activated receptor-gamma2 gene.

    Stefan N, Fritsche A, Häring H, Stumvoll M.

    Diabetes. 2001 May;50(5):1143-8.PMID: 11334419 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism.

    Stumvoll M, Häring H.

    Diabetes. 2002 Aug;51(8):2341-7. Review.PMID: 12145143 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences.

    Douglas JA, Erdos MR, Watanabe RM, Braun A, Johnston CL, Oeth P, Mohlke KL, Valle TT, Ehnholm C, Buchanan TA, Bergman RN, Collins FS, Boehnke M, Tuomilehto J.

    Diabetes. 2001 Apr;50(4):886-90.PMID: 11289057 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Pro12Ala of the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower serum insulin levels in nonobese African Americans: the Atherosclerosis Risk in Communities Study.

    Kao WH, Coresh J, Shuldiner AR, Boerwinkle E, Bray MS, Brancati FL; Atherosclerosis Risk in Communities Study.

    Diabetes. 2003 Jun;52(6):1568-72.PMID: 12765972 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study.

    Lindi VI, Uusitupa MI, Lindström J, Louheranta A, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Tuomilehto J; Finnish Diabetes Prevention Study.

    Diabetes. 2002 Aug;51(8):2581-6.PMID: 12145174 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    The peroxisome proliferator-activated receptor-gamma2 gene polymorphism (Pro12Ala) beneficially influences insulin resistance and its tracking from childhood to adulthood: the Bogalusa Heart Study.

    Li S, Chen W, Srinivasan SR, Boerwinkle E, Berenson GS; Bogalusa Heart Study.

    Diabetes. 2003 May;52(5):1265-9.PMID: 12716762 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Association between Pro12Ala polymorphism of the PPAR-gamma2 gene and insulin sensitivity in Brazilian patients with type-2 diabetes mellitus.

    Tavares V, Hirata RD, Rodrigues AC, Monte O, Salles JE, Scalissi N, Speranza AC, Hirata MH.

    Diabetes Obes Metab. 2005 Sep;7(5):605-11.PMID: 16050954 [PubMed - indexed for MEDLINE]Related articles

    19.

    Fetal and maternal peroxisome proliferator-activated receptor gamma2 Pro12Ala does not influence birth weight.

    Pfab T, Poralla C, Richter CM, Godes M, Slowinski T, Priem F, Halle H, Hocher B.

    Obesity (Silver Spring). 2006 Nov;14(11):1880-5.PMID: 17135601 [PubMed - indexed for MEDLINE]Related articles

    20.

    Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes.

    Mancini FP, Vaccaro O, Sabatino L, Tufano A, Rivellese AA, Riccardi G, Colantuoni V.

    Diabetes. 1999 Jul;48(7):1466-8.PMID: 10389855 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity